The FDA nod means trial sponsors can use Apple Watch's A-fib history as a secondary endpoint in trials without having to do ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today we ponder, how much will the advisory committee meeting ...

A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its ...

As Americans strive to move beyond Covid-19, it is important to acknowledge that for their 7 million immunocompromised fellow citizens the pandemic continues to be an ongoing challenge.

The immense potential benefits of biotechnology are profoundly vulnerable to misuse. Better screening of synthetic DNA orders is a key barrier to bad actors.

Two congenitally deaf children can hear after being treated with a gene therapy, according to new data from an ongoing clinical trial.

In 2020, James Sulzer’s personal and professional lives suddenly intersected after his then 4-year-old daughter sustained a devastating injury. As a researcher and associate professor in physical ...

A livestream of the event will be embedded below at 1 p.m. ET. t took decades for scientists to come up with treatments that could slow the ...

A new study on real-world prescriptions of Leqembi, the Alzheimer's drug from Eisai and Biogen, suggests there are already stark disparities in the rollout of the new treatment.

There’s long been a global shortage of the BCG vaccine for bladder cancer. But since ImmunityBio won FDA approval for Anktiva, an immunotherapy meant to be used along with the BCG vaccine, production ...